We have cloned PEX15 which is required for peroxisome biogenesis in Saccharomyces cerevisiae. 
Introduction
The peroxisome is a nearly ubiquitous organelle of the eukaryotic cell and is bounded by a single membrane. The proteins [recently renamed as peroxins (Pex) ] and targeting signals involved in peroxisomal protein import are highly conserved between most eukaryotes. Peroxisomal matrix proteins are synthesized on free polysomes, and are imported post-translationally into the organelle (reviewed by Lazarow and Fujiki, 1985) . Translocation
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across the peroxisomal membrane does not require complete unfolding of the protein (Walton et al., 1995) , and some proteins can oligomerize before the actual translocation takes place (Glover et al., 1994; McNew and Goodman, 1994; Elgersma et al., 1996b; Häusler et al., 1996) .
Sorting to the peroxisome requires the presence of a peroxisomal targeting signal (PTS). Most peroxisomal matrix proteins possess a PTS1 signal, which is present at the extreme C-terminus and requires a basic amino acid at the penultimate position and a hydrophobic amino acid at the ultimate position (Gould et al., 1987; Elgersma et al., 1996b) . The PTS1 is recognized by the cytosolic PTS1 receptor, Pex5p, which docks at the SH3 domain of the peroxisomal integral membrane protein, Pex13p (Elgersma et al., 1996a; Erdmann and Blobel, 1996; Gould et al., 1996) . A smaller subset of peroxisomal matrix proteins uses the N-terminal PTS2 signal (Swinkels et al., 1991) , which is recognized by Pex7p, the PTS2 receptor (Rehling et al., 1996; Zhang and Lazarow, 1996) . Some proteins lacking a PTS1 or PTS2 sequence are still able to enter the peroxisomes in a Pex5p-dependent manner, indicating that additional topogenic sequences may exist (Kragler et al., 1993; Elgersma et al., 1995) .
Since the mechanism of import seems to be very conserved between higher and lower eukaryotes, several laboratories have exploited yeasts as model organisms for peroxisomal protein import and biogenesis. The isolation of yeast mutants involved in peroxisome assembly (now collectively called pex mutants) has resulted in the identification of several proteins (peroxins) involved in peroxisome biogenesis (reviewed in Distel et al., 1996; Elgersma and Tabak, 1996) . This has not only resulted in a substantial increase in our knowledge of how peroxisomes are assembled, but has also facilitated the cloning of the corresponding human genes, many of which are defective in peroxisome-related disorders (reviewed in Subramani, 1997) .
Despite our increasing knowledge regarding aspects of peroxisomal import of matrix proteins, little is known about the targeting of peroxisomal membrane proteins. Although it has been demonstrated that several peroxisomal membrane proteins are synthesized on free polysomes (Fujiki et al., 1984; Bodnar and Rachubinski, 1991) and that at least two of them (Pmp70 and Pmp22) are inserted directly into the peroxisomal membrane (Diestelkötter and Just, 1993; Imanaka et al., 1996) , these data are insufficient rigorously to rule out the involvement of the endoplasmic reticulum (ER). In this study, we report the cloning of a novel gene (PEX15) which encodes an integral peroxisomal membrane protein involved in peroxisome biogenesis. We have identified its peroxisomal targeting signal (mPTS) and found that Pex15p accumulates in the ER under various conditions (overexpression, (B) Hydrophobicity plot of Pex15p using the algorithm described by Kyte and Doolittle (1982) . The window size used is 15 amino acids. The predicted transmembrane domain is highlighted.
deletion of the mPTS or C-terminal fusion proteins).
These results suggest that Pex15p may be targeted to the peroxisomes via the ER, which is of great importance in the understanding of peroxisome biogenesis.
Results

Cloning of the PEX15 gene
The pex15.1 mutant (previously called pas21.1 mutant) was obtained using a positive selection procedure for the isolation of pex mutants in Saccharomyces cerevisiae (Elgersma et al., 1993) . It was used to clone the corresponding PEX15 wild-type gene by functional complementation with a genomic library. Nucleotide sequencing of the smallest complementing insert (1641 bp) revealed an open reading frame (ORF) of 1152 bp, encoding a 383 amino acid protein with a predicted mass of 43.6 kDa ( Figure 1A ). More recently, this gene has also been sequenced by the Genome Sequencing Project of S.cerevisiae (accession No. Z74786/YOLO44W). Despite the fact that most peroxins are relatively well conserved in evolution , we have been unable to identify a putative human ortholog of Pex15p in the databases. In addition, database searches did not reveal any significant homology to other proteins. A KyteDoolittle hydrophobicity plot of Pex15p revealed several putative hydrophobic regions, but only one region reached the threshold value of 1.6, which is generally used as a criterion for prediction of transmembrane domains (TMDs) ( Figure 1B ). Programs which predict putative TMDs according to the algorithms of Klein et al. (1985) or Kyte and Doolitttle (1982) indeed classified Pex15p as an , 27 000 g pellet (P) and 27 000 g supernatant (S) were analyzed by Western blotting. For NH-Mdh3p detection, we used the NH antibody; otherwise we used the antibodies directed against the proteins as indicated. (B) Pex13p location in oleate-induced wild-type and pex15∆ cells. A 27 000 g organellar pellet fraction was layered at the bottom of a sucrose flotation gradient and centrifuged for 18 h at 150 000 g. Fractions obtained from these gradients were analyzed by Western blotting using αPex13p antibodies. The graph represents the density at 4°C in g/cm 3 .
integral membrane protein with a single TMD at its carboxy-terminus (amino acids 332-349).
pex15∆ cells are disturbed in the import of peroxisomal matrix proteins
To study the function of Pex15p, most of the chromosomal PEX15 gene (corresponding to amino acids 13-301 of the 383 amino acid Pex15p) was replaced by the LEU2 gene, resulting in the pex15∆ strain. The pex15∆ mutant was crossed with the pex15.1 strain. The resulting diploids were unable to grow on oleate, indicating that the authentic PEX15 gene had been cloned and deleted. Furthermore, pex15∆ regained its ability to grow on oleate when it was transformed with the PEX15 gene, indicating that the growth defect of pex15∆ on oleate is reversible.
We next analyzed the localization of peroxisomal enzymes in the pex15∆ mutant. Oleate-induced wild-type and pex15∆ cells were fractionated, and the organellar pellet and the cytosolic supernatant were analyzed. Thiolase, peroxisomal catalase (Cta1p) and peroxisomal malate dehydrogenase (Mdh3p) were present in the organellar (27 000 g) pellet fraction of wild-type cells, whereas they were present in the cytosolic (27 000 g) supernatant fraction of pex15∆ cells (Figure 2A ). This demonstrates that the import of enzymes containing a PTS1 (catalase, Mdh3p) or PTS2 (thiolase) is disturbed in pex15∆.
In contrast to the peroxisomal matrix proteins, we observed that on average 40-80% of the peroxisomal membrane proteins Pex13p (Elgersma et al., 1996a) and Pat1p (Hettema et al., 1996) was present in the organellar (27 000 g) pellet fraction obtained from pex15∆ cells (shown for Pex13p in Figure 2A ). This indicates either that membrane proteins aggregate to large cytosolic protein complexes in pex15∆, or that they are targeted to peroxisomal remnants ('ghosts'). To distinguish between these two possibilities, the crude organellar pellet was layered at the bottom of a two-step sucrose flotation gradient, which was spun for 18 h at 150 000 g (Walworth et al., 1989; Heyman et al., 1994) . Protein aggregates will remain at the bottom, whereas proteins attached to membranes will rise to the lighter sucrose density. As shown in Figure 2B , Pex13p floated to a density of 1.17 g/cm 3 (peak fraction) when the organellar pellet obtained from wild-type cells was used. Flotation of Pex13p was also observed when using the organellar pellet obtained from pex15∆ cells, although Pex13p was now found at a slightly lighter density (peak at 1.11 g/cm 3 ).
This indicates that membrane proteins are still targeted to a membrane. Moreover, expression of a Pex13p-green fluorescent protein (GFP) fusion protein in pex15∆ cells showed a punctate fluorescence for GFP, suggesting that pex15∆ cells have peroxisomal remnants.
Pex15p is a low abundance integral peroxisomal membrane protein
Antibodies to Pex15p recognized a protein of the expected size in wild-type cells, but not in pex15∆ cells (Figures 2A and 3A) . Western blot analysis of cell lysates prepared from cells grown on either glucose, glycerol or oleate generally showed a 5-to 10-fold induction of Pex15p in cells grown on oleate, compared with cells grown on glucose or glycerol ( Figure 3A ). Northern blot analysis confirmed this result, and in addition it revealed that Pex15p was expressed at a low level ( Figure 3B ).
To determine the location of the Pex15p, we fractionated oleate-grown wild-type cells. Pex15p was present exclusively in the organellar pellet fraction (Figure 2A ). Its location was analyzed further by subjecting a post-nuclear (1000 g) supernatant (PNS) to Nycodenz density gradient centrifugation, which separates peroxisomes from the mitochondria and ER, leaving cytosolic proteins on top of the gradient. Fractions of this gradient were used for Western blotting using thiolase as a peroxisomal marker, Sec61p as an ER marker and the flavoprotein subunit of succinate dehydrogenase as a mitochondrial marker. Using the Pex15p antibody, we observed that the bulk of Pex15p co-migrated with the peroxisomal marker enzyme, indicating that Pex15p is a peroxisomal protein ( Figure 3C ). Nevertheless, we frequently observed that the most dense peroxisomal fractions contained relatively low amounts of Pex15p. In addition, Pex15p was often in lighter fractions which contain small amounts of peroxisomal matrix protein ( Figure 3C ). The relevance of this finding is unclear.
The subcellular localization of Pex15p was analyzed further using electron microscopy. Since the Pex15p anti- Northern blot analysis of PEX15 and CTA1 expression. RNA was isolated from cells grown on glucose, glycerol or oleate; 10 µg of total RNA was used for each lane of the agarose gel. After blotting onto nitrocellulose, the filters were probed with radiolabeled PEX15 and CTA1 probes of comparable specific activity. The PEX15 autoradiograph was exposed 15 times longer than the CTA1 autoradiograph. An actin probe used as control showed the same amount of mRNA in every lane (not shown). (C) Subcellular location of Pex15p. Oleate-grown wild-type cells were fractionated and the post-nuclear supernatant was analyzed on a Nycodenz gradient. Fractions were subjected to SDS-PAGE, blotted and probed with the antibodies listed. Thiolase is a marker for peroxisomes, Sec61p for the ER and flavoprotein for the mitochondria. Fraction 1 corresponds to the bottom fraction, whereas fraction 15 corresponds to the top fraction. (D) Resistance of Pex15p to carbonate extraction. A portion of the organellar pellet was extracted with Tris buffer pH 8.0. Following centrifugation, the pellet was extracted with Tris buffer pH 8.0, 1 M NaCl and, after further centrifugation, this pellet was finally extracted with 100 mM sodium carbonate pH 11.5. Following a final centrifugation step, equivalent portions of pellet (P) and supernatant (S) were used for Western blotting with the antibodies as indicated. Glycerol-grown cells were labeled with [ 35 S]methionine for 7 min at 22°C, and chased by addition of cold methionine and yeast extract for the indicated time (in minutes) at 28°C. After immunoprecipitation using the Pex15p antibody, samples were subjected to SDS-PAGE using a 10% gel. After fixation, the gel was subjected to fluorography. bodies did not yield a signal using immunoelectron microscopy, Pex15p was epitope tagged with the NH tag (Elgersma et al., 1996b) at the amino-terminus. This protein could restore the formation of normal peroxisomes in the pex15∆ mutant when expressed under the control of its own promoter or the peroxisomal catalase (CTA1) promoter on a single-copy plasmid (NH-Pex15p/CEN), indicating that the tag did not impair the functioning of Pex15p (not shown). We observed a clear labeling of the peroxisomal membrane in oleate-grown wild-type cells expressing NH-Pex15p/CEN (see below, Figure 5A ), whereas no labeling was observed in untransformed control cells (not shown). These results demonstrate that Pex15p is a peroxisomal membrane protein.
Since the primary amino acid sequence suggests that Pex15p has a TMD near its C-terminus, we used a crude organellar pellet fraction for carbonate extraction analysis, a treatment that removes peripheral but not integral proteins from the membrane (Fujiki et al., 1982) . As expected, most of the thiolase was already removed after extraction with Tris-HCl at pH 8.0, whereas the mitochondrial integral membrane protein Tom40p could not be extracted either by 1 M NaCl or by carbonate at pH 11.5 ( Figure  3D ). We found that Pex15p was not extractable with 1 M NaCl, and it was largely (60-80%) resistant to carbonate extraction, suggesting that Pex15p is indeed an integral peroxisomal membrane protein ( Figure 3D ).
Pex15p is a tail-anchored type II membrane protein
To determine the topology of Pex15p, we used cells lacking either cytosolic malate dehydrogenase (mdh2∆) or peroxisomal malate dehydrogenase (mdh3∆). We have shown previously that mdh3∆ cells are unable to grow on plates containing oleate as sole carbon source and that mdh2∆ cells can not grow on ethanol (Van Roermund et al., 1995a) . By making mutations in the PTS1 of Mdh3p, we could demonstrate further that 5% or less of Mdh3p import is already sufficient to complement the mdh3∆ mutant (Elgersma et al., 1996b) . In addition, cytosolically mislocalized Mdh3p∆PTS1 is able to rescue the growth defect of mdh2∆ cells on ethanol. We made use of this observation by expressing various hybrid proteins of Pex15p fused to Mdh3p∆PTS1 in mdh2∆ and mdh3∆ cells. Mdh3p-Pex15p was targeted to peroxisomes, but did not complement the mdh3∆ mutant. Mdh3p-Pex15p (partially) complemented mdh2∆ cells, indicating that the N-terminus is facing the cytosol. Conversely, Pex15p fused to the N-terminus of Mdh3p∆PTS1 (Pex15p-Mdh3p) was unable to complement the mdh2∆ mutant whereas (partial) complementation of mdh3∆ cells was observed. This suggests that the C-terminus of Pex15p is lumenal.
Additional evidence for a type II topology (N-terminus in the cytosol, C-terminus in the lumen) was obtained by immunoelectron microscopy analysis of cells expressing NH-Pex15p. Most gold particles were present at the cytosolic side of the peroxisomal membrane when using the NH antibodies, suggesting that the N-terminus is facing the cytosol (see below, Figure 5A ).
Taken together with the sequence analysis of Pex15p, which predicts one TMD at the C-terminus, the results suggest that Pex15p is a tail-anchored type II membrane protein. This finding is confirmed by several additional experiments described later.
Pex15p is phosphorylated
Interestingly, we noted that Pex15p never migrates as a single sharp band upon being subjected to SDS-PAGE (see Figures 2A, 3A and C) . This heterogeneity in the observed molecular weight was more pronounced when Pex15p was overexpressed ( Figure 4A ). The molecular weight heterogeneity was also observed when the NH antibody was used to detect NH-Pex15p, which rules out alternative initiation of translation or N-terminal breakdown ( Figure 4A) . Furthermore, the size of the αNH-reactive protein bands changed as expected when truncated forms of NH-Pex15p (∆12 and ∆30) were expressed, ruling out the possibillity of C-terminal breakdown ( Figure  4A ). The largest increase of the expected molecular weight of the protein was observed when the last 55 amino acids were removed (NH-Pex15p∆55) ( Figure 4A ). The modification was lost when only the C-terminal 82 amino acids of Pex15p were fused to NH-Mdh3p lacking its PTS1 signal [NH-Mdh3p-Pex15p(C82)]. These experiments suggest that the modification was in the cytosolic domain of Pex15p ( Figure 4A ).
To test whether Pex15p is post-translationally modified, cells expressing NH-Pex15p/2µ or a C-terminal truncated form of the protein (NH-Pex15p∆55/2µ) were labeled with [ 35 S]methionine for 7 min, followed by a chase with excess cold methionine ( Figure 4B ). Slower migrating forms of Pex15p were observed during the chase time, indicating that Pex15p is indeed post-translationally modified. Since Pex15p has several Thr and Ser residues which might serve as substrates for phosphorylation, we made lysates of cells which expressed Pex15p from the CTA1 promoter (Pex15p/CEN) and treated them with potato acid phosphatase (PAP). The higher molecular weight species could be removed by this treatment, suggesting that Pex15p is indeed phosphorylated ( Figure 4C ). The same result was obtained for NH-Pex15p∆55/2µ (not shown).
Although phosphorylation can occur in the ER of mammals, to our knowledge phosphorylation does not occur in the ER or peroxisome lumen in S.cerevisiae. We wanted to exploit this to derive additional (in vivo) evidence for a type II topology. Therefore, we fused a small Ser/Thr-rich epitope at either the N-or C-terminus of Pex15p, resulting in ST-Pex15p and Pex15p-ST respect-ively (see Materials and methods). When expressed from a CEN plasmid under the control of either the PEX15 or CTA1 promoter, both fusion proteins could restore normal peroxisome assembly in the pex15∆ strain and were targeted to the peroxisomes (data not shown). We observed a drastic increase in the phosphorylation of Pex15p when cells expressed ST-Pex15p at both expression levels (shown for CTA1-ST-Pex15p in Figure 4C ). No increased phosphorylation was observed when cells expressed Pex15p-ST ( Figure 4C ). These data provide additional evidence for a type II topology of Pex15p. 
Overexpression of Pex15p leads to impaired peroxisome assembly and profound ER membrane proliferation
The effect of overexpression of Pex15p was analyzed by expressing it under the control of the CTA1 promoter on a multicopy plasmid (NH-Pex15p/2µ). Remarkably, when oleate-grown wild-type cells expressing NH-Pex15p/2µ were subjected to subcellular fractionation, we found that Ͻ50% of catalase and thiolase were present in the crude (27 000 g) organellar pellet fraction, and gradient analysis showed a shift of peroxisomes to a lighter density (not shown). We therefore examined the peroxisome morphology of wild-type cells overexpressing NH-Pex15p by electron microscopy. In most cells, we found a strong induction of membranes containing Pex15p ( Figure 5B ). These membranes resembled karmellae: a morphological arrangement of membranes around the nucleus caused by the overexpression of resident ER proteins (Wright et al., 1988) . We found that the membranes containing Pex15p were mostly wrapped around the nucleus, and we often observed a continuity between the membranes and the nuclear envelope in potassium permanganate-fixed cells ( Figure 5C and inset). In cells where membrane proliferation was reduced or absent, we often observed the presence of Pex15p in the nuclear envelope. These results demonstrate that overexpressed Pex15p accumulates in the ER, where it causes membrane proliferation.
Using immunoelectron microscopy, we could hardly detect normal looking peroxisomes in wild-type cells overexpressing Pex15p/2µ, which is consistent with the abnormal position of these peroxisomes in gradients. Sometimes we observed thiolase-containing peroxisomes from which several membranes protruded ( Figure 5D ). Additional evidence that overexpression of Pex15p was obstructing the formation of normal peroxisomes was obtained from overexpressing the peroxisomal membrane proteins NH-Pex3p or NH-Pex13p together with overexpressed Pex15p. Both proteins were found in the Pex15p-induced membranes (shown for NH-Pex3p in Figure 5E ). Significant membrane proliferation did not occur when these proteins were expressed with normal levels of Pex15p, although we occasionally observed some ER labeling in the case of Pex3p.
Taken together, these EM analyses indicate that both the peroxisomal and the ER membranes strongly proliferate upon overexpression of Pex15p and that the peroxisomal membrane proteins NH-Pex3p and NHPex13p are present in the Pex15p-induced membranes. These observations suggest that Pex15p overexpression interfered with a maturation step in peroxisome formation and that Pex15p might be targeted to peroxisomes via the ER. To test the important possibility that the ER is directly involved in peroxisome biogenesis, we analyzed the targeting of Pex15p in more detail.
Overexpressed Pex15p carries an ER-specific modification
Many proteins which are destined for the secretory pathway undergo modifications in the ER or in ER-derived compartments. For instance, N-linked glycosylation has been of great value in monitoring the trafficking of proteins through the secretory pathway. In S.cerevisiae, N-and O-linked glycosylation occur exclusively in the ER or ER-derived compartments. Therefore, finding such a modification on a protein is firm evidence for targeting to, and temporal residence in, the secretory pathway. Pex15p has putative N-linked glycosylation sites on the predicted cytosolic domain ( Figure 1A ). Endoglycosidase H (EndoH) or N-glycosidase F (not shown) treatment of lysates from cells expressing NH-Pex15p/2µ caused no molecular weight shift for Pex15p, whereas carboxypeptidase Y (CPY) was entirely shifted to the deglycosylated species ( Figure 6A ). This result suggests that Pex15p is not N-glycosylated. After immunoprecipitation using the Pex15p antibody, samples were subjected to SDS-PAGE using a 10% gel. After fixation, the gel was subjected to fluorography for 8 weeks. The 35 S-labeled samples were 50-fold diluted to get the same intensity as the 2-[ 3 H]mannose-labeled samples. (C) N-glycosylation of Pex15-invertase hybrid proteins. Lysates were obtained from oleate-grown cells expressing Pex15p-invertase fusion proteins under the control of the CTA1 or PEX15 promoter, treated with (ϩ) or without (-) EndoH and subjected to Western blotting using the αPex15p antibody. 'Hybrid-Nglyc' indicates the core-glycosylated hybrid protein; 'Hybrid*' indicates the coreglycosylated hybrid protein after EndoH treatment (does not remove the first GlcNAc); 'Hybrid' indicates the unglycosylated form.
The lumenal tail of Pex15p contains several Ser/Thr residues which might be a target for O-mannosylation. In contrast to higher eukaryotes, O-glycosylation in S.cerevisiae is confined strictly to the secretory pathway (reviewed by Herscovics and Orlean, 1993) . O-Glycosylation in S.cerevisiae, often referred to as O-mannosylation, is initiated by the integral ER membrane protein Dol-Pmannose synthase, for which S.cerevisiae has only one gene. The first mannose is added by an integral ER membrane protein, Dol-P mannose:(Ser/Thr) mannosyltranferase, for which S.cerevisiae possesses seven genes (Gentzsch and Tanner, 1996) . Subsequent mannose chain elongation involves α1,2 and α1,3 linkages and takes place in the Golgi, resulting in a total of five mannoses per Ser or Thr residue. In contrast to N-glycosylation, no consensus site has been elucidated. Since O-mannosylation of a few Ser/Thr residues would result in only a minor shift in molecular weight (Ͻ0.2 kDa per mannose), we could not easily use this criterion to test whether Pex15p is indeed a target for O-mannosylation. Therefore, we tested whether Pex15p was able to bind to concanavalin A (ConA). We did observe binding to ConA of overexpressed as well as endogenous Pex15p, in a manner competable by the addition of α-methyl mannoside. However, we obtained similar results with in vitro translated Pex15p, which made this method unreliable. We then tested O-mannosylation of Pex15p by incubating cells expressing NH-Pex15p/2µ with [ 3 H]mannose. After immunoprecipitation with αPex15p antibody, we could detect 3 H-labeled Pex15p, suggesting that at least some NH-Pex15p/2µ is indeed O-mannosylated ( Figure 6B) . As a control, we used cells expressing a truncated form of Pexp15p which lacked the TMD and lumenal tail (NHPex15p∆55/2µ). As expected, we did not observe [ 3 H]mannose labeling of this protein ( Figure 6B ). These experiments provide firm biochemical evidence, and corroborate the morphological evidence presented earlier, that (overexpressed) Pex15p is targeted to the ER. Although we do not have a clear picture of the carbohydrate moiety on Pex15p, it most probably does not have mannose chain elongation (which occurs in the Golgi) since it was not recognized by an antibody that detects mannose in α1,2 and α1,3 linkages (data not shown). This suggests that residence of Pex15p remains limited to the ER.
Pex15p-invertase accumulates in the ER
Although O-mannosylation provided evidence for trafficking to the ER, the labeling with [ 3 H]mannose was too insensitive to determine whether endogenous Pex15p had traveled through the ER. We therefore tried to generate a substrate for N-glycosylation by fusing Pex15p to mature invertase, which lacks its ER signal sequence. Invertase is N-glycosylated at 10-12 of its 13 potential Asn residues. Mature (lacking its signal sequence) invertase fused to the N-terminus of Pex15p and expressed from the PEX15 promoter (Inv-Pex15p/CEN) was normally targeted to peroxisomes. In agreement with our finding that the N-terminus of Pex15p is facing the cytosol, we did not observe N-glycosylation ( Figure 6C ). In contrast, when invertase was fused to the C-terminus of Pex15p and expressed from the CTA1 promoter (Pex15p-Inv/CEN), we found a shift of the molecular weight corresponding to core N-glycosylation of the invertase moiety. Treatment with EndoH showed that the shift is indeed caused by N-glycosylation ( Figure 6C ). Not all of the Pex15p-Inv is N-glycosylated. This might indicate that the unmodified protein has not been in the ER, or that some Pex15p-Inv is not inserted correctly in the membrane. The first possibility was ruled out because gradient analysis revealed that both the modified and the unmodified Pex15p-Inv co-migrated with the ER marker, and we failed to detect any Pex15p-Inv in the peroxisomes (not shown). This implies that either the fusion to invertase or the increased expression level interferes with normal peroxisomal targeting of Pex15p. In order to distinguish between these two possibilities, and to see whether the fusion expressed at endogenous Pex15p levels would go to the ER, we expressed Pex15p-Inv also under the control of the PEX15 promoter from a single-copy plasmid. We found very similar results to those observed with Pex15p-Inv under the control of the CTA1 promoter; a core N-glycosylated form and a non-modified species ( Figure 6C) . Notably, the ratio between the two had not changed. In addition, we found again that both species remained in the ER, with none of the protein present in peroxisomes (not shown). As expected, N-glycosylation was not observed when invertase was fused to the C-terminus of a truncated Pex15p which lacks its TMD (Pex15p∆55-Inv) ( Figure  6C ). Complete core N-glycosylation was observed if invertase was fused to Pex15p which only lacks its lumenal tail (Pex15∆30-Inv), indicating that the lumenal tail is not required for the targeting to the ER ( Figure 6C) . Furthermore, these experiments show that even at endogenous expression levels, Pex15p contains the topogenic signals to direct invertase to the ER.
Since the Pex15p-Inv fusion protein was no longer targeted to the peroxisome, we also tried to make Pex15p a substrate for N-glycosylation by fusing only a small epitope to the C-terminus of Pex15p which contained a consensus N-glycosylation site (Pex15p-Nglyc, see Materials and methods). Despite accumulation in the ER of the overexpressed Pex15-Nglyc, the protein was not a substrate for N-glycosylation and therefore not useful for studying Pex15p trafficking (data not shown).
The lumenal tail is required for targeting to peroxisomes, but not for targeting to the ER The results described above indicate that Pex15p contains a topogenic signal that can target it to the ER, and a signal that can target it to peroxisomes. These signals may overlap or may be distinct from each other. Like most other peroxisomal membrane proteins, the Pex15p protein does not contain a PTS1-like or PTS2-like targeting signal. Sequences responsible for the targeting of membrane proteins to the peroxisomal membrane have been delineated for the peroxisomal membrane proteins Pex3p and Pmp47 (Höhfeld et al., 1992; Baerends et al., 1996; Dyer et al., 1996; Wiemer et al., 1996) . Both mPTSs are close to (but do not include) a transmembrane region and are located on the lumenal side of the membrane. By analogy with these findings, we expected the lumenal tail of Pex15p to contain the mPTS. In addition, we noticed that there is some homology between the tail of Pex15p and the published mPTSs ( Figure 7A ).
To test whether the tail was indeed required for targeting to the peroxisomes, we made C-terminal deletions of Pex15p and expressed them under the control of the CTA1 promoter ( Figure 7B ). To analyze the locations of these proteins, we subjected a PNS derived from oleate-grown cells to Nycodenz density gradient centrifugation. As can be seen in Figure 7C , wild-type NH-Pex15p expressed under the control of the CTA1 promoter behaved indistinguishably from endogenous Pex15p, showing co-migration with the peroxisomal marker (compare Figure 7C with 3C).
Deletions up to 12 amino acids did not affect the targeting of NH-Pex15p ( Figure 7D ), nor its ability to complement the pex15∆ growth defect on oleate. When the last 30 amino acids were deleted, leaving only four amino acids downstream of the hydrophobic domain, the protein could only complement the pex15∆ mutant very weakly. The bulk of NH-Pex15p∆30 accumulated in a compartment of intermediate density, which co-migrates with most of the ER marker Sec61p ( Figure 7E ). Immuno- electron microscopy analysis of these cells revealed only very little peroxisomal labeling, but we were unable to detect significant labeling of other compartments at this expression level (not shown). These results indicate that the amino acids 354-371, which reside in the lumenal tail, are required for targeting Pex15p to the peroxisome. Notably, this domain is not responsible for targeting Pex15p to the ER, since NH-Pex15p∆30 accumulates in the ER which was also found for Pex15p∆30-Inv as described earlier.
The minimal mPTS of Pex15p overlaps with the ER targeting signal
As shown earlier, deletion of the C-terminal 30 amino acid tail of Pex15p caused the protein to accumulate in the ER. The question arises then whether or not accumulation in the ER is a result of mistargeting of Pex15p caused by the lack of its mPTS. Alternatively, Pex15p is first targeted to the ER and needs its mPTS to be sorted subsequently to peroxisomes. In the latter case, we expected (i) that the C-terminal 34 amino-acids ('tail') would not be sufficient to direct a reporter protein to peroxisomes, and (ii) that the lumenal tail would function only as an mPTS in combination with the ER targeting signal on Pex15p.
To test these predictions, we asked whether the last 34 amino acids of Pex15p could target a reporter enzyme to the peroxisomal membrane. For this, we made use of NHepitope-tagged Mdh3p from which the five C-terminal amino acids, including its PTS1, had been deleted. We have demonstrated previously that this protein is mistargeted to the cytosol (Elgersma et al., 1996b) . Gradient analysis of mdh3∆ cells expressing the NH-Mdh3p-Pex15p(C34)/ CEN fusion protein under the control of the CTA1 promoter revealed that NH-Mdh3p-Pex15p(C34) remained on top of the gradient, and no peroxisomal targeting was detected. In addition, NH-Mdh3p-Pex15p(C34) could not complement the mdh3∆ mutant, suggesting that Ͻ5% of this protein was targeted to peroxisomes. This indicates that, at least in the context of this reporter protein, the last 34 amino acids are not sufficient for targeting Mdh3p to peroxisomes ( Figure 8A ). This result differs from the observations described for CbPmp47, PpPex3p and HpPex3p for which it has been shown that the lumenal mPTS (without a TMD) was sufficient to direct a reporter protein to the peroxisome (Baerends et al., 1996; Dyer et al., 1996; Wiemer et al., 1996) .
We tried to delineate the mPTS further by making a fusion protein with Mdh3p which contained only the TMD and lumenal tail of Pex15p [NH-Mdh3p-Pex15p(C53)]. However, this protein was unstable (data not shown). No instability was observed when we made a fusion protein of NH-Mdh3p∆PTS1 fused to the last 82 amino acids of Pex15p [NH-Mdh3p-Pex15p(C82)/CEN]. Gradient analysis showed that a portion of this protein co-migrated with the peroxisomal marker enzyme, and some of the protein was found at lighter densities ( Figure 8B ). Immunoelectron microscopy analysis confirmed that the NH-Mdh3p-Pex15p(C82) fusion protein was partially targeted to the peroxisomal membrane ( Figure 5F ). In addition, some of the protein was present in the ER since we frequently observed labeling of the nuclear envelope ( Figure 5G ). Overexpression of this protein [NH-Mdh3p-Pex15p(C82)/2µ] resulted in the proliferation of membranes, similar to what was seen with the overexpressed wild-type Pex15p ( Figure 5H ).
Taken together with the Pex15p deletion experiments described above, the results indicate that the signal for directing Pex15p to the peroxisome is located between amino acids 302 and 371 (see Figure 7B ). This overlaps with the ER targeting signal which resides between amino acids 302 and 353. 
Discussion
Pex15p is a phosphorylated protein required for peroxisome assembly
We have cloned and sequenced the PEX15 gene by functional complementation of the pex15.1 mutant (previously called pas21.1, Elgersma et al., 1993) . Disruption of the gene results in mistargeting to the cytosol of PTS1-and PTS2-containing peroxisomal matrix proteins, indicating that Pex15p plays an important role in peroxisome assembly and that it is therefore a true member of the peroxin family . Like most pex mutants of S.cerevisiae (Erdmann and Kunau, 1992) , pex15∆ cells lack morphologically detectable peroxisomes as judged by electron microscopy. However, this probably reflects a detection problem rather than a true absence of peroxisomal remnants, since further analysis revealed that peroxisomal membrane proteins (Pex13p and Pex13p-GFP) were still targeted to peroxisomal membrane remnants.
Pex15p is the first peroxin shown to be post-translationally modified. Previous studies have identified one other presumed peroxisomal membrane protein which is phosphorylated, but the gene encoding this 63 kDa protein has not been identified yet (Skorin et al., 1986 ). It will be of particular interest to test whether or not the observed phosphorylation is important for Pex15p function.
Pex15p is a type II tail-anchored membrane protein
We demonstrated that Pex15p is a (tail-anchored) integral peroxisomal membrane protein with a type II topology (N cyt -C lumen ). Evidence for the N-terminus being cytosolic was provided by a number of observations: (i) the Mdh3p-Pex15p fusion complements mdh2∆ and not mdh3∆; (ii) immunoelectron microscopy showed that the αNH antibodies labeled the cytosolic side of the peroxisomal membrane when cells expressed NH-Pex15p; and (iii) a Ser/Thr-rich epitope was phosphorylated only when fused to the N-terminus of Pex15p. Evidence for a lumenal C-terminus was provided by a Pex15p-Mdh3p fusion (complements mdh3∆ and not mdh2∆), and by a fusion to invertase which was only glycosylated when fused to the C-terminus of Pex15p.
The knowledge that Pex15p is a (bitopic) type II tailanchored membrane protein is important for understanding how it is targeted to the peroxisome. With the possible exception of one membrane protein, it has been shown that most peroxisomal membrane proteins are synthesized on free polyribosomes, and post-translationally inserted into the peroxisomal membrane (Fujiki et al., 1984; Bodnar and Rachubinski, 1991) . In contrast, most integral membrane proteins of the ER are synthesized on membrane-bound ribosomes and inserted co-translationally. Consequently, this criterion can be used to investigate whether a peroxisomal membrane protein travels via the ER. However, tail-anchored proteins which insert into the ER are predicted to insert post-translationally since at least part of the transmembrane domain will still be buried in the ribosome before the termination codon is reached. Recently, this prediction has been confirmed by demonstrating that the tail-anchored protein synaptobrevin inserts via a novel pathway into the ER, independently of SRP and Sec61p (Kutay et al., 1995) . Therefore, it is very likely that Pex15p will also be inserted post-translationally into membranes.
Overexpression of Pex15p causes ER membrane proliferation
A striking feature of Pex15p is its capacity to proliferate the ER membrane upon overexpression. This phenomenon has been well described for overexpression of several residential ER proteins such as the cytochromes P-450 and b5, and HMG-CoA reductase (Jones and Fawcett, 1966; Wright et al., 1988; Vergeres et al., 1993) . These proteins induce karmellae, a morphological arrangement of membranes around the nucleus. Interestingly, overexpression of the yeast HMG-CoA reductase Hmg1p, leads to the formation of karmellae whereas overexpression of Hmg2 induces short stacks of membranes. By exchanging segments between Hmg1p and Hmg2p, it was shown that in the context of HMG-CoA reductase, the karmellae formation was caused by a lumenal loop (Parrish et al., 1995) . Likewise, we found that the morphology of the induced membranes changed to large vesicle-like structures when the lumenal tail (NH-Pex15p∆30) was deleted (not shown). For cytochrome b5, it was shown that a membrane anchor was required for karmellae production (Vergeres et al., 1993) . Our Pex15p analyses support this finding. When the TMD of Pex15p was deleted (Pex15p∆55), membrane proliferation did not occur (data not shown), whereas the C-terminal 82 amino acids of Pex15p fused to Mdh3p led to membrane proliferation ( Figure 5H ).
The nature of the mPTS of Pex15p
Sequences responsible for the targeting of membrane proteins to the peroxisomal membrane have been delineated for Pex3p of S.cerevisiae (Sc), Pichia pastoris (Pp) and Hansenula polymorpha (Hp), and for Candida boidini (Cb) Pmp47 (Höhfeld et al., 1992; Baerends et al., 1996; Dyer et al., 1996; Wiemer et al., 1996) . Both mPTSs are close to, but do not include, a transmembrane region and are located on the lumenal side of the membrane. In agreement with these findings, we found that the lumenal tail of Pex15p is required for peroxisomal targeting. Furthermore, as shown in Figure 7A , there is some homology with the tail of Pex15p and the published mPTSs. This alignment is somewhat different from that used by Dyer et al. (1996) and is based on information available since their publication. However, the mPTS of Pex15p differs in two important aspects from that of CbPmp47. Deletion of the mPTS of Pmp47 results mainly in mistargeting to the cytosol whereas deletion of the mPTS of Pex15p results in ER accumulation. Furthermore, in contrast to CbPmp47, the lumenal domain alone of Pex15p is not sufficient to target a protein to the peroxisome. Peroxisomal targeting of Pex15p requires, in addition, a domain (including a TMD) which is also able to direct Pex15p to the ER.
Pex15p and Pex3p have some striking similarities. Overexpression of Pex15p leads to ER proliferation, and overexpressed NH-Pex3p can be found in these same membranes. Furthermore, we showed that the C-terminal 82 amino acids were able to target a reporter protein to both the ER and the peroxisome. Similarly, it has been observed that the first 16 amino acids of the HpPex3p were able to target a reporter protein to both the ER and the peroxisome (Baerends et al., 1996) . These results indicate that Pex15p and Pex3p may be targeted to the peroxisomes via the ER, and that there are two distinct classes of mPTS (discussed below).
Pex15p may be targeted to the peroxisome via the ER
Multiple lines of evidence show that overexpressed Pex15p has an effect on the proliferation of ER membranes, and that this protein is targeted to both the ER and the peroxisome. First, in cells overexpresssing Pex15p from a multicopy plasmid, a massive proliferation of membranes was observed. These membranes are ER derived because they are morphologically contiguous with the nuclear envelope and are similar to the membrane proliferation produced by overexpression of other ER membrane proteins such as HMG-CoA reductase and cytochrome b5. Under these conditions, growth of the cells on oleate was unaffected, despite the observation that overexpression of Pex15p interfered with normal peroxisome biogenesis. Thus at least some of the overexpressed protein must have been targeted to the peroxisomes in a functional state. Second, the overexpressed Pex15p was labeled with mannose which, according to the information available currently, is added solely in the secretory pathway in S.cerevisiae. Third, the accumulation and N-glycosylation of Pex15p-invertase fusions in the ER provides additional support for the conclusion that Pex15p has an ER targeting signal and that the C-terminal lumenal tail of Pex15p does see the ER lumen. Importantly, this fusion behaved identically when expressed from the endogenous PEX15 promoter, from a single-copy plasmid, showing thereby that the ER targeting and modification of this protein could not be attributed to overexpression alone. Finally, we have provided ample evidence using deletions of Pex15p, as well as fusions with other proteins, that there exist within Pex15p both ER and peroxisomal targeting signals.
We have been unable rigorously to rule out the possibility of mistargeting due to the technical difficulties faced in carrying out pulse-chase experiments with endogenous Pex15p. The low levels of endogenous Pex15p and the long exposure times required for the mannose labeling have greatly hampered our ability to detect an ER-specific modification on the endogenous protein. Without the presence of irrefutable ER modifications on the endogenous protein, pulse-chase experiments would not allow us to distinguish between pro-peroxisomes of lighter density and true ER. If any of the sec mutants affect the targeting of Pex15p to peroxisomes, the use of such mutants may be of great help in addressing the targeting of Pex15p and Pex3p. However, these analyses were impeded by the fact that most sec mutants are present in a strain background (SEY6210) that cannot utilize oleate.
The origin of peroxisomes
If the ER involvement as described above truly reflects the nature of the trafficking of (some) peroxisomal membrane proteins, this would be in conflict with the current view of the origin of peroxisomes. The cellular and evolutionary origin of peroxisomes has long been a matter of debate, and has recently aroused new interest. Historically, peroxisomes were thought to form by budding from the ER, thereby sharing their origin with other DNA-less organelles bounded by a single membrane. This interpretation was based primarily on many morphological studies, showing that peroxisomes and (smooth) ER are closely associated, and occasionally connected, with each other (Novikoff and Shin, 1964 ; reviewed by Lazarow et al., 1980) . However, the finding that many (if not all) peroxisomal matrix proteins and at least a few peroxisomal membrane proteins are synthesized on free polysomes, followed by post-translational import from the cytosol, strongly suggested that peroxisomes are formed by growth and division of pre-existing (pro-) peroxisomes, and that all peroxisomal membrane and matrix proteins are imported from the cytosol to the peroxisome directly (Lazarow and Fujiki, 1985) . In order to explain the morphological and biochemical data in a consistent fashion, the peroxisome reticulum hypothesis was put forward, which implies that peroxisomes may be connected with each other via tubular structures (Lazarow et al., 1980) . Additional evidence for the existence of such a network came from histochemical studies which suggested the existence of a peroxisome-forming sheet (Ohno and Fujii, 1990) .
Although the growth and division model has hardly been challenged with contradicting data, the model leaves us still with a few unsolved problems. For instance, the origin of the pro-peroxisome or peroxisome-forming sheets (which are very similar to smooth ER) remains unclear. In addition, all the peroxisome biogenesis mutants isolated thus far can be complemented by the corresponding wildtype gene. Since several of these mutants (e.g. pex3∆) do not have any recognizable peroxisomes, it is hard to envisage where the new peroxisomes came from during the complementation of such mutants with the corresponding genes.
Assuming that the ER is involved directly in peroxisome biogenesis, some peroxisomal membrane proteins would be imported directly from the cytosol to the organelle using one type of mPTS (mPTS1). Another class, which would include Pex15p, goes to the peroxisomes via the ER using a related, but distinct mPTS (mPTS2) (Subramani, 1991) . The two types of mPTSs are distinguished primarily by the fact that the first is recognized in the cytosol and acts without the requirement for an ER targeting signal, while the second requires an ER targeting signal for its function (as shown here for Pex15p) and acts from the ER lumen. The lumenal domain has to be recognized by a sorting machinery which accumulates proteins destined for the peroxisome on the ER membrane. Thereafter, vesicles containing these proteins would bud off subsequently from the ER. These vesicles can function immediately as a pro-peroxisome by importing matrix and some membrane proteins from the cytosol, or they may be able to fuse with each other or with mature peroxisomes to allow organelle growth.
Our model of a direct involvement of the ER in peroxisome biogenesis provides an alternative explanation for the observation that some peroxisomal membrane protein and peroxisomal matrix proteins first appear in an intermediate or light density fraction after synthesis, and later in a dense fraction (Lüers et al., 1993; Van Roermund et al., 1995b) . The observed heterogeneity in protein content between the so-called light and dense peroxisomes may reflect the different stages of peroxisome biogenesis, starting with ER-derived vesicles and ending with mature peroxisomes. Recent findings that two NSF-like ATPases (Pex1p and Pex6p) are required for peroxisome biogenesis, and that these are located on vesicles distinct from mature peroxisomes (Faber et al., 1998) , provide additional support for our proposal for a role of vesicles in peroxisome biogenesis. This model would also provide an explanation for the mechanism of recruitment of phospholipids during peroxisome proliferation.
Materials and methods
Strains and culture conditions
The S.cerevisiae strains used in this study were: BJ1991 (MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3) ; COP161 U7 (MATa, ade2, ura3, lys) (used for back-crossing of pex15.1); pex15∆ (Pex15::LEU2, MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3); pex15.1 (Y84) (pex15, MATα, leu2, trp1, ura3-251, prb1-1122, pep4-3); pex15.1-1d (pex15, MATα, leu2, ura3, lys2 ) (used for cloning of the wild-type gene); pex15. MATα, ade2, ura3, trp1, lys2 ) (used for crossing with pex15∆); and Escherichia coli DH5α (recA, hsdR, supE, endA, gyrA96, relA1, lacZ) .
Yeast transformants were selected and grown on minimal medium containing 0.67% yeast nitrogen base without amino acids (YNB-WO) (Difco), 2% glucose and L-amino acids (20 mg/ml) as needed. Cells transformed with a genomic library were plated on minimal medium containing 0.3% glucose, to allow direct replica-plating onto oleate plates. Oleic acid plates contained 0.1% oleic acid/0.4% Tween-40, 0.67% YNB-WO, 0.1% yeast extract (Difco) and amino acids (20 mg/ml) as needed. To obtain oleate-induced cells, cells were grown for a minimum of 24 h on 0.3% glucose minimal medium, and subsequently were grown for 15-18 h on oleate medium [0.5% potassium phosphate buffer (pH 6.0), 0.3% yeast extract, 0.5% peptone (Difco) and 0.1% oleic acid/0.2% .
For expression studies, cells were grown on 0.3% glucose minimal medium for at least 24 h, and were grown subsequently on medium containing 0.5% potassium phosphate buffer (pH 6.0), 0.3% yeast extract, 0.5% peptone and either 2% glucose, 2% glycerol or 0.1% oleic acid/ 0.2% Tween-40 as carbon source. The cultures were inoculated at a density such that they reached OD 600 ϭ 0.7-1.0 after~15 h.
Cloning and sequencing of the PEX15 gene
The pex15.1 mutant was back-crossed with strain COP161 U7. After tetrad dissection, the progeny of spore pex15.1-1d were used for transformation with a genomic single-copy (YCp50) and multicopy library (YEp13) (Nasmyth and Tatchell, 1980; Rose et al., 1987) . Transformed cells were plated onto selective glucose medium and replica-plated onto minimal oleate plates. Among 14 000 Yep13 library transformants, four clones were able to grow on oleate. No complementing clones were obtained among the 12 000 Ycp50 library transformants. The complementing plasmids of the positive clones were rescued and transformed to E.coli DH5α. From all four positive clones, we recovered a plasmid containing an 11 kb insert (p21.2). From two clones, we recovered an additional plasmid containing a 4.8 kb insert (p21.1). Both plasmids were able to complement the pex15.1 growth defect on oleate after re-transformation. Restriction analysis revealed that the 4.8 kb insert of p21.1 was part of the 11 kb insert of p21.2, suggesting that p21.1 is the result of a recombination event of p21.2, either in E.coli or in yeast. To localize the PEX15 gene on the 4.8 kb insert, subclones were made from p21.1 and tested for their ability to complement the mutant. A complementing 2500 bp EcoRI fragment (p21.9) was reduced further in size by ExoIII nuclease treatment. The smallest complementing clone resulting from this procedure contained an insert of 1641 bp (p21.9-R2). Both strands of this insert were entirely sequenced with the T7 DNA polymerase sequencing kit (Pharmacia), which is based on the dideoxyribonucleotide chain terminating method (Sanger et al., 1977) .
Disruption of the PEX15 gene
The LEU2 gene was cloned in the SalI site of pUC19, resulting in pUC19-LEU2. An NsiI fragment of the PEX15 gene was cloned in the PstI site of pUC19-LEU2 (p21.20). This plasmid was then digested with SmaI and SacI, and was re-circularized by ligating a ScaI (blunted)-SacI fragment of the PEX15 gene in this plasmid (p21.21). The insert of this plasmid was amplified by PCR using universal sequencing primers, and this DNA was used to transform BJ1991 cells. Leu ϩ transformants were analyzed by Southern blotting for correct integration in the PEX15 gene. The disruption deleted the amino acids 13-301 of Pex15p.
Construction of Pex15p expression plasmids
A BamHI site was introduced just before the start codon by PCR on p21.9 with the 5Ј P121* (Table I) primer and a 3Ј universal primer. The 5Ј end of the gene was sequenced until the NsiI site, and the remainder of the gene was swopped with the NsiI-HindIII fragment of the authentic PEX15 gene obtained from p21.9-R2 (resulting in p21.26). The BamHIHindIII insert of p21.26 containing the entire PEX15 gene, was placed downstream of the CTA1 promoter with or without the NH tag (NHPex15p/CEN, p21.27; Pex15p/2µ, 21.31) (CTA1 expression plasmids are described in Elgersma et al., 1996b) . To facilitate additional manipulations, the SacI-HindIII fragment containing the NH-PEX15 gene was cloned in the SacI and HindIII sites of the CTA1 promoter expression plasmids in which the multiple cloning site was replaced by the P1/P2 adaptor, which resulted in p21.44 (NH-Pex15p/CEN) and 21.45 (NHPex15p/2µ). A PEX15 promoter expression plasmid was made by PCR on P21.9 using a 5Ј universal primer and introducing a BamHI site at the 3Ј end of the promoter using primer P16. The PCR product was digested with EcoRI (831 bp upstream of the PEX15 ORF and BamHI and cloned in the EcoRI and BamHI sites of YCpLAC33 (p21.60). Pex15p and its derivatives were cloned in the BamHI and HindIII sites of this plasmid to obtain endogenous expression levels.
Pex15p∆55 was constructed by replacing the PstI-HindIII fragment of the PEX15 gene by the PstI-HindIII fragment of p21.9-R2 (obtained by ExoIII nuclease treatment). This resulted in a replacement of the last 
55 amino acids by the tripeptide Lys-Leu-Lys [NH-Pex15p∆55/CEN (p21.33), NH-Pex15p∆55/2µ (p21.34)]. Construction of Pex15p∆12 (p21.58) and Pex15p∆30 (p21.68) was achieved by PCR using a 5Ј specific PEX15 primer and a 3Ј primer with the desired truncation (P13, P14). To exclude mutations due to PCR, we sequenced the 3Ј end of the constructs until the BstXI site, and replaced the remainder of the gene with the wild-type PEX15 sequence. The targeting constructs with MDH3 were made by cloning the ScaIHindIII fragment of p21.26 in the PstI (blunt)-HindIII site of pEL149, which contains the NH-MDH3 gene, described in Elgersma et al. (1996b) , resulting in NH-Mdh3p-Pex15p(C82)/CEN (p21.38) and NH-Mdh3p-Pex15p(C82)/2µ (p21.39). NH-Mdh3p-Pex15p(C34)/CEN was constructed by PCR on p21.44 using the 3Ј P111 and a 5Ј universal primer. The obtained PCR fragment encoding the last 34 amino acids of Pex15p was digested with PstI-HindIII and cloned in the PstI and HindIII sites of pEL 149.
ST-Pex15p was constructed by replacing the SacI-BamHI fragment of p21.44 (containing the NH tag) by the adaptor (P84/P85). The encoded amino acids of this adaptor are: MSTSSSSSSTGS. The resulting ST-PEX15 gene was cloned as a SacI-HindIII fragment in the various expression plasmids. To construct Pex15p-ST and Pex15p-Nglyc, we first removed the stop codon of PEX15 by PCR on p21.44 using a 5Ј universal primer and the 3Ј primer P81. The PCR fragment obtained was digested with BstXI and HindIII, and this was used to replace the 5Ј end of PEX15 in p21.45. The resulting plasmid (p21.83) was partially sequenced and digested with HindIII and EcoRI, followed by a ligation with the ST adaptor (P86/87; encoding the amino acids SLTSSSSSSS), or with the Nglyc adaptor (P105/106; encoding the amino acids SLGVNASGGLASI). The resulting PEX15-ST and PEX15-Nglyc genes were cloned as BamHI-EcoRI fragments in the appropriate expression plasmids.
All of the invertase (SUC2) fusions were constructed by PCR with Vent polymerase (NEB). For the Pex15p-invertase constructs with the CTA1 promoter, an upstream primer, PUC19-40, was hybridized upstream of the CTA1 promoter-PEX15 in plasmid p21.31. A universal primer (T3) was used as an upstream primer for the PEX15 promoter-containing constructs utilizing pBSPEX15, which contains PEX15 in a pBluescript vector, as the template. Downstream primers were designed to hybridize just before the stop codon (P21FLINV), or at codons which create the truncations (P21∆55INV, P21∆30INV). Downstream primers contained a HindIII site for in-frame fusion to invertase in the vector pSEYC308 (CEN, URA3) (Johnson et al., 1987) . Invertase-Pex15p was constucted by PCR using the overlap extension method. A set of complementary primers containing the fusion joint (FUJ1 and FUJ2), encoding the next to last amino acid of invertase followed by the second amino acid of Pex15 and additional flanking sequences on both sides, were used to create the fusion joint and provide the overlap for the second round of PCR. An upstream primer (BP21INV) contained a BamHI site, followed by the first two codons of PEX15, then 16 nuclotides that hybridize to SUC2 starting at the codon for amino acid 3 of the mature (signal sequence cleaved) protein. The downstream primer was the universal primer T7. Primers FUJ1 and T7 were used to amplify PEX15 from pBSPEX15. Primers BP21INV and FUJ2 were used to amplifiy invertase from pSEYC308. Both products were gel purified and~50 ng of each mixed for PCR with BP21INV and T7 primers. The resulting product was purified, digested with BamHI and HindIII, and cloned into p21.60.
Antibodies
The Pex15p protein was expressed in E.coli by cloning an NsiI-HindIII fragment [obtained from a PEX15 clone (p21.9-R3) treated by ExoIII nuclease] in the PstI-HindIII site of plasmid pQE-9 (Qiagen). The resulting 6ϫHis-tagged protein encompassing amino acids 12-329 of Pex15p subsequently was expressed in E.coli and purified by Nichelating chromatography under denaturing conditions according to the manual provided by Qiagen. The protein was purified further by SDS-PAGE, visualized with 0.25 M KCl, 1 mM dithiothreitol (DTT), and subsequently excised and eluted from the gel in elution buffer [50 mM Tris (pH 8.0), 0.1% SDS, 0.1 mM EDTA, 5 mM DTT, 0.15 M NaCl]. This highly purified protein was used to immunize rabbits. The antibody was used at a 1:5000 dilution for Western blotting, and 1:500 for immunoprecipitations.
The thiolase and NH antibodies are described by Elgersma et al. (1996b) and were both used at a 1:5000 dilution. The Pex13p (1:3000) antibody is described by Elgersma et al. (1996a) . The antibody against Cta1p (1:10 000) will be described elsewhere. Antibodies against Sec61p (1:3000) and flavoprotein subunit of succinate dehydrogenase (1:3000) were a kind gift of R.Schekman and I.Scheffler, respectively.
Subcellular fractionation and Nycodenz gradient analysis
Subcellular fractionations of oleate-grown cells were performed as described by Van der Leij et al. (1992) , in the presence of protease inhibitors [1 mM phenylmethylsulfonyl fluoride (PMSF) and 2 mg/ml of chymostatin, leupeptin, antipain and pepstatin]. Continuous 16-35% Nycodenz gradients were used (30 ml), with a cushion of 4 ml of 42% Nycodenz dissolved in 5 mM 2[N-morpholino]ethane sulfonic acid (MES) (pH 6.0), 1 mM EDTA, 1 mM KCl and 8.5% sucrose. The sealed tubes were centrifuged for 2.5 h in a vertical rotor at 29 000 g at 4°C. Afterwards, fractions were collected and analyzed by SDS-PAGE and Western blotting.
Sucrose flotation gradients
A two-step gradient was made by resuspending the organellar pellet in 500 ml of 60% sucrose (w/w) in sucrose gradient buffer [5 mM MES (pH 6.0), 1 mM KCl, 1 mM EDTA]. This was transferred to a Beckman centrifuge tube and overlaid with 2.4 ml of 50% (w/w) sucrose in sucrose gradient buffer, and overlaid with 2.4 ml of 20% (w/w) sucrose in sucrose gradient buffer. The samples were spun for 18 h at 150 000 g, and fractions were analyzed by SDS-PAGE and Western blotting.
Carbonate extraction
An organellar pellet (27 000 g) prepared from wild-type cells was resuspended in 100 mM Tris buffer (pH 8.0). Following freezing and centrifugation (233 000 g for 60 min), the pellet was extracted with 100 mM Tris buffer (pH 8.0), 1 M NaCl. After another centrifugation step, the pellet was extracted with 100 mM sodium carbonate (pH 11.5). This was centrifuged once more, and equivalent portions of pellet (P) and supernatant fractions (S) were layered in each lane of an SDSpolyacrylamide gel, blotted onto nitrocellulose and probed with the antibodies indicated. All extraction steps were performed at 4°C, in the presence of protease inhibitors (1 mM PMSF and 2 mg/ml of chymostatin, leupeptin, antipain and pepstatin).
Alternatively, a freshly prepared organellar pellet was used directly for carbonate extraction, and further treated as described above. This procedure gave the same result with respect to the distribution of the membrane proteins.
EndoH and PAP treatment
Cells from a 50 ml overnight-grown oleate culture (OD 600 ϭ 0.8) were pelleted, washed and lysed with glass beads. The pellet was resuspended in 500 µl of phosphate-buffered saline (PBS) containing 0.5% SDS and 1% β-mercaptoethanol, and cell debris was removed by centrifugation for 1 min at 8000 g. The supernatant was boiled for 5 min. For PAP treatment, 10 µl of cell-free lysate was added to 40 µl of PAP buffer (50 mM MES pH 6.0, 1 mM DTT) containing 1 U of PAP (Boehringer) and protease inhibitors as described above. Samples were incubated for 18 h at 28°C. For EndoH treatment, 10 µl of cell-free lysate were added to 40 µl of EndoH buffer (100 mM NaAc pH 4.5, 1% β-mercaptoethanol, 0.5% SDS) containing 2 mU of EndoH (Boehringer) and protease inhibitors. Samples were incubated for 2 h at 37°C. Mock treatments were treated in a similar manner, but without the addition of enzyme.
Fusion proteins with invertase were expressed in oleate as described above. Two OD 600 equivalents of each strain were harvested by centrifugation and resuspended in 10% trichloroacetic acid (TCA). Following at least 15 min on ice, the samples were pelleted, washed twice with cold acetone and dried. The pellet was resuspended in 160 µl of 1% β-mercaptoethanol, 0.5% SDS and lysed by glass bead vortexing and boiling. The samples were then cleared by centrifugation and 120 µl of cleared lysate were mixed with 30 µl of 0.25 M Na citrate pH 5.5. The samples were split into two aliquots. To one sample, 1 µl (1 mU) of Endo H was added. All samples were incubated at 37°C for 2 h. Samples were mixed 1:1 with 2ϫ sample buffer and heated to 95°C for 5 min prior to SDS-PAGE and Western blotting as described above.
Miscellaneous
[ 35 S]Methionine or (D)-2-[ 3 H]mannose labeling of cells and the subsequent immunoprecipitation were carried out essentially as previously described (Elgersma et al., 1996b) , with the exception that we used 150 µCi of [ 35 S]methionine for pulse-chase experiments and 500 µCi for [ 3 H]mannose labeling. We used minimal glycerol medium for all labelings, and added 0.2 mg/ml methionine and cysteine plus 0.5% yeast extract for chases. When indicated, cells were chased in rich oleate medium, by diluting them 10 times in rich oleate supplemented with 0.2 mg/ml methionine and cysteine. Isotopes were obtained from NEN.
Western blotting was performed essentially as described in Elgersma et al. (1996a) . Blots were incubated with either IgG-coupled alkaline phosphatase staining (NBT/BCIP; KPL Laboratories) or with goat antirabbit peroxidase conjugate (ECL; Amersham) and further treated as recommended by the manufacturers.
For TCA lysates, cells (50 ml of culture OD 600 ϭ 0.7) were spun, washed and collected in a 2 ml Eppendorf tube. After addition of 500 µl of 10% TCA and~200 µl of glass beads, the cells were broken by vigorous vortexing for 30 min at 4°C. Cell debris was pelleted by spinning for 30 s at 6000 r.p.m., and the supernatant was centrifuged further for 20 min at 12 000 r.p.m. at 4°C. The pellet was washed once with acetone, dried and resuspended in Laemmli sample buffer for SDS-PAGE analysis.
For immunoelectron microscopy analyis, oleate-induced cells were fixed with 2% paraformaldehyde and 0.5% glutaraldehyde. Ultra-thin sections were prepared as described by Gould et al. (1990) . Potassium permanganate-fixed sections were prepared as described by Wiemer et al. (1996) .
